Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products

Overview

Lots (6)

• Insulin Pumps

  This Lot aims to offer Patch Insulin Pumps and Tethered Insulin Pumps and associated consumables or accessories. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £140,000,000 to £150,000,000 Excluding VAT in the first year. These are approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

  £620,000,000

• Continuous Glucose Monitors

  This Lot aims to offer Continuous Glucose Monitors and associated consumables or accessories. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £75,000,000 to £95,000,000 in the first year. These are approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. It is expected that the yearly spend for years 2 , 3 and 4 of the Framework Agreement will rise significantly.

  £446,932,000

• Software and Diabetes Management Systems

  Applications and/or software that contributes to the functionality of a closed loop insulin delivery system. Products that connect with blood glucose sensors and insulin pumps to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with diabetes. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £15,000 - £17,000 in the first year. These are approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

  £68,000

• Insulin Pumps

  This Lot aims to offer Patch Insulin Pumps and Tethered Insulin Pumps and associated consumables or accessories.

  Won by Advanced Therapeutics (UK) LtdWon by Air Liquide Healthcare LtdWon by GlucoRx LtdWon by Insulet International LtdWon by Medtronic LimitedWon by Medtrum LtdWon by Ypsomed Ltd

• Continuous Glucose Monitors

  This Lot aims to offer Continuous Glucose Monitors and associated consumables or accessories.

  Won by Abbott Laboratories LimitedWon by Dexcom International LtdWon by GlucoRx LtdWon by Medtronic LimitedWon by Medtrum LtdWon by Novo Nordisk LimitedWon by Urathon Europe Limited

• Software and Diabetes Management Systems

  Applications and/or software that contributes to the functionality of a closed loop insulin delivery system. Products that connect with blood glucose sensors and insulin pumps to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with diabetes.

  Won by Advanced Therapeutics (UK) LtdWon by Air Liquide Healthcare LtdWon by Dexcom International LtdWon by Glooko LimitedWon by GlucoRx LtdWon by Medtronic LimitedWon by Medtrum LtdWon by Ypsomed Ltd

Award outcome

Awarded value

£1,067,000,000

Award date

5 November 2025

Contract period

— → 29 April 2027

Contract ending soon? Skim tracks incumbents and flags recompetes early. Start for Free to set up alerts.

How to win this tender

Skim reads the notice and every document attached to it, scores the fit against your company profile for a clear bid or no-bid call, then drafts each answer from your own evidence and past bids. You review, refine and submit — on time, with every requirement covered.

See exactly how Skim’s agents do this →

Comparing platforms? Skim is set against the alternatives for pre-tender intelligence, tender management software and bid management software.